Phase IIa trial of Locteron in treatment-naive patients with hepatitis C genotype 1 (SELECT-1).
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2011
At a glance
- Drugs Interferon alpha-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Acronyms SELECT-1
- Sponsors OctoPlus
- 01 Apr 2011 Results published in the Journal of Viral Hepatitis.
- 02 Nov 2010 Results reported at AASLD, according to a OctoPlus media release.
- 23 Apr 2008 Updated results presented at EASL 2008.